![James Murphy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James Murphy
Directeur Financier/CFO chez MUSTANG BIO, INC.
Postes actifs de James Murphy
Sociétés | Poste | Début | Fin |
---|---|---|---|
MUSTANG BIO, INC. | Comptroller/Controller/Auditor | 19/01/2024 | - |
Directeur Financier/CFO | 19/01/2024 | - |
Historique de carrière de James Murphy
Anciens postes connus de James Murphy
Sociétés | Poste | Début | Fin |
---|---|---|---|
DECIBEL THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 07/10/2022 | 22/09/2023 |
Directeur Financier/CFO | 07/10/2022 | 22/09/2023 | |
GI DYNAMICS, INC. | Directeur Financier/CFO | 05/05/2016 | 01/12/2017 |
Secrétaire Général | 05/05/2016 | 01/12/2017 | |
Treasurer | 05/05/2016 | 01/12/2017 | |
ONCOTELIC THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 07/03/2011 | 29/12/2011 |
Directeur Financier/CFO | 01/03/2004 | 31/03/2012 | |
Whatman, Inc.
![]() Whatman, Inc. Industrial MachineryProducer Manufacturing Whatman, Inc. develops, manufactures, and markets separation technology devices. Its products are used for filtration, purification and storage of chemicals, and other liquids & samples. It is a subsidiary of Whatman Plc. The company was founded in 1961 and is headquartered in Florham Park, NJ. | Directeur Financier/CFO | 01/01/2001 | 01/05/2003 |
HMSR, Inc.
![]() HMSR, Inc. Medical SpecialtiesHealth Technology HMSR, Inc. developed products for blood transfusion and collection procedures. The company was founded by Eugene J. Zurlo and was headquartered in Boston, MA. | Comptroller/Controller/Auditor | 01/01/1994 | 01/01/2001 |
Directeur Financier/CFO | 01/01/1994 | 01/01/2001 | |
Sumitomo Pharma America, Inc.
![]() Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Comptroller/Controller/Auditor | 01/01/1990 | 01/01/1994 |
Formation de James Murphy
College of the Holy Cross (Massachusetts) | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
Opérationnelle
Director of Finance/CFO | 6 |
Comptroller/Controller/Auditor | 5 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 7 |
Producer Manufacturing | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
ONCOTELIC THERAPEUTICS, INC. | Health Technology |
DECIBEL THERAPEUTICS, INC. | Health Technology |
MUSTANG BIO, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Whatman, Inc.
![]() Whatman, Inc. Industrial MachineryProducer Manufacturing Whatman, Inc. develops, manufactures, and markets separation technology devices. Its products are used for filtration, purification and storage of chemicals, and other liquids & samples. It is a subsidiary of Whatman Plc. The company was founded in 1961 and is headquartered in Florham Park, NJ. | Producer Manufacturing |
HMSR, Inc.
![]() HMSR, Inc. Medical SpecialtiesHealth Technology HMSR, Inc. developed products for blood transfusion and collection procedures. The company was founded by Eugene J. Zurlo and was headquartered in Boston, MA. | Health Technology |
Sumitomo Pharma America, Inc.
![]() Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Health Technology |
GI Dynamics, Inc.
![]() GI Dynamics, Inc. Medical SpecialtiesHealth Technology GI Dynamics, Inc. engages in the development and commercialization of a medical device system intended for treatment of patients with type 2 diabetes and reduction of obesity. Its pipeline product is EndoBarrier, an endoscopically delivered medical device intended to help restore healthy blood sugar levels and reduce weight. The company was founded by Andy Levine on March 24, 2003 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- James Murphy
- Expérience